Cundy Kenneth C 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Apr 7, 2025
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-04+115,037→ 115,037 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (115,037 underlying)
Footnotes (1)
- [F1]One-sixteenth (1/16) of the shares subject to the option vested and became exercisable on April 4, 2025, with the remainder scheduled to vest and become exercisable in fifteen (15) equal quarterly installments on each July 15, October 15, January 15, and April 15 thereafter, vesting fully on January 15, 2029, in each case, subject to the Reporting Person's continued service to the Issuer through each vesting date.